க்ளென் ஸ்சுழ்மான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from க்ளென் ஸ்சுழ்மான். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In க்ளென் ஸ்சுழ்மான் Today - Breaking & Trending Today

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

Assets expand immunology portfolio to include B-cell therapy and macrophage modulation - - IND-enabling studies are ongoing and will support the transition of these assets to clinical development in 20222023 - Aurinia Pharmaceuticals Inc. today announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of . ....

United States , United Kingdom , Neil Solomons , Rob Huizinga , Glenn Schulman , Peter Greenleaf , Aurinia Pharmaceuticals Inc , Exchange Commission Electronic Document Gathering , Drug Administration , Riptide Bioscience Inc , Thunderbolt Pharma Inc , Investor Relations Corporate Communications , Chief Executive Officer , Recombinant Fc Protein Targeting , Thunderbolt Pharma , B Cell Activating Factor , Proliferation Inducing Ligand , United State Food , Chief Medical Officer , Riptide Bioscience , Executive Vice President , British Columbia , Annual Report , Canadian Securities Administrator System , Electronic Document Analysis , Exchange Commission ,

Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Brinda Balakrishnan , Peter Greenleaf , Glenn Schulman , Company Phase , Aurinia Pharmaceuticals Inc , Exchange Commission Electronic Document Gathering , Company Board Of Directors , Corporate Communications , European Union , European Medicines Agency , Aurinia Pharmaceuticals , Otsuka Pharmaceutical Co Ltd , Company Quarterly Report On Form , Balakrishnan Is Group Vice , Business Development Of Biomarin Pharmaceutical Inc , Otsuka Cash , Chief Executive Officer , Group Vice President , Business Development , Biomarin Pharmaceutical , Quarter Ended June , Quarterly Report , British Columbia , Annual Report ,

Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript

Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , Peter Greenleaf , Glenn Schulman , David Martin , Brinda Balakrishnan , Neil Solomons , Max Colao , Alethia Young , Justin Kim , Maurice Raycroft , Michael Hayden , Emily Cantor Fitzgerald , Joe Miller , Joseph Schwartz , Aurinia Pharmaceuticals Inc , Canadian Security Authority , Group Vice , Aurinia Pharmaceuticals Second Quarter Earnings Call , Ken Cacciatore Cowen Company Analyst , Cowen Company , Justin Kim Oppenheimer Company Analyst , Cantor Fitzgerald , Business Development Of Biomarin , Corporate Communications , Oppenheimer Company , Vice President ,

Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange

Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
Aurinia Pharmaceuticals Inc. a commercial stage biopharmaceutical company advancing therapies for severe autoimmune diseases, announced today it will voluntarily delist the common shares of the Company from the Toronto Stock Exchange effective as of the close of trading on July 30, 2021. The Company’s common shares will no longer be traded on the TSX but will continue to trade on the Nasdaq Capital Market under …
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company), a commercial stage biopharmaceutical company advancing therapies for severe autoimmune diseases, announced today it will voluntarily delist the common shares of the Company from the Toronto Stock Exchange (TSX) effective as of the close of trading on July 30, 2021. The Company’s common shares will no longer be traded on the TSX but will continue to trade on the Nasdaq Capital Market (Nasdaq) under the ....

United States , United Kingdom , Glenn Schulman , Aurinia Pharmaceuticals Inc , Company Nasdaq , Toronto Stock Exchange , Aurinia Pharmaceuticals , Company Manual , Investor Relations Corporate Communications , Nasdaq Capital Market , British Columbia , Corporate Communications , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , க்ளென் ஸ்சுழ்மான் , ஒரினிய மருந்துகள் இன்க் , நிறுவனம் நாஸ்டாக் , டொராண்டோ ஸ்டாக் பரிமாற்றம் , ஒரினிய மருந்துகள் , நிறுவனம் கையேடு , முதலீட்டாளர் உறவுகள் பெருநிறுவன தகவல்தொடர்புகள் , நாஸ்டாக் மூலதனம் சந்தை , பிரிட்டிஷ் கொலம்பியா , பெருநிறுவன தகவல்தொடர்புகள் ,

Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs

Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

United States , New York , United Kingdom , Emory University , Indiana University , Temple University Hospital , Ellenm Ginzler , Glenn Schulman , Christine Lindsay , Dana Lynch , Grady Health System , Ohio Department Of Health , Lupus Foundation Of America Tri , Health Science Center , Temple University Hospital Lupus Program , Indiana University Hospital , Lupus Foundation Of America , Department Of Medicine , Lupus Foundation Of America Georgia Chapter , Downstate Health Science University , Aurinia Pharmaceuticals Inc , Lupus Foundation Of America Indiana Chapter , Brooklyn Foundation , Downstate Health Sciences University , Rheumatology Division , Postmedia Network Inc ,